2024-517258-85-00CompletedPhase 1
Optical PD-L1 imaging using Quantitative Fluorescence Endoscopy in locally advanced esophageal cancer using durvalumab-680LT: a phase I multicenter feasibility and safety study
Source: EU CTIS (euclinicaltrials.eu) · Last updated 21 Nov 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- First submitted
- 15 Oct 2024
- Start date
- 21 Nov 2024
- Lead sponsor
- Universitair Medisch Centrum Groningen
- Diseases
- Gastric and esophageal cancer
- EU CT number
- 2024-517258-85-00
- EudraCT number
- 2020-004714-35
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 36
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Medisch Centrum Groningen | Groningen | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.